The value of whole-exome sequencing as a first-tier genetic test in the diagnosis of skin disorders

FHS
August 23, 2023
12:42 pm

The genetic etiology by whole-exome sequencing (WES).

NVIDIA banks on generative AI to pursue partnerships with biotechs – Pharmaceutical Technology

NVIDIA has been in the news this year via announced partnerships to forward genAI’s use in the pharmaceutical industry. Credit: NurPhoto via Getty Images. The

October 20, 2023

Amid backlash to harm reduction, addiction experts warn against reprising ‘war on drugs’

SAN FRANCISCO — Amid what feels like an ever-worsening drug crisis here, locals and politicians alike are fed up. Overdose death rates remain near all-time

May 16, 2024

Individualized SABR for Lung Tumors Yields Low Recurrence Rates

Individualizing stereotactic ablative radiotherapy (SABR) dose and fractionation according to tumor size, location, and histological characteristics was associated with “excellent” local control and low rates

September 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.